Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1960 4
1961 7
1962 3
1963 6
1964 9
1965 1
2018 1
2020 1
2021 3
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Response letter to the Editor.
Conaghan PG, Guehring H, Moreau F, Daelken B, Ladel C, Guenther O, Reinstrup Bihlet A, Wirth W, Eckstein F, Hochberg M. Conaghan PG, et al. Among authors: guenther o. Semin Arthritis Rheum. 2022 Feb;52:151839. doi: 10.1016/j.semarthrit.2021.05.001. Epub 2021 May 8. Semin Arthritis Rheum. 2022. PMID: 34006385 Free article. No abstract available.
Model-based meta-analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus.
Goteti K, Garcia R, Gillespie WR, French J, Klopp-Schulze L, Li Y, Mateo CV, Roy S, Guenther O, Benincosa L, Venkatakrishnan K. Goteti K, et al. Among authors: guenther o. CPT Pharmacometrics Syst Pharmacol. 2024 Feb;13(2):281-295. doi: 10.1002/psp4.13083. Epub 2023 Dec 4. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38050332 Free PMC article.
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.
Eckstein F, Hochberg MC, Guehring H, Moreau F, Ona V, Bihlet AR, Byrjalsen I, Andersen JR, Daelken B, Guenther O, Ladel C, Michaelis M, Conaghan PG. Eckstein F, et al. Among authors: guenther o. Ann Rheum Dis. 2021 Aug;80(8):1062-1069. doi: 10.1136/annrheumdis-2020-219181. Epub 2021 May 7. Ann Rheum Dis. 2021. PMID: 33962962 Free PMC article. Clinical Trial.
[THE THYMUS GLAND AS A PRIMARY ORGAN OF IMMUNITY].
GUENTHER O. GUENTHER O. Dtsch Med Wochenschr. 1964 May 15;89:987-90. doi: 10.1055/s-0028-1111248. Dtsch Med Wochenschr. 1964. PMID: 14140889 Review. German. No abstract available.
Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient-level placebo (Standard-of-Care) data to enable model-informed drug development.
Goteti K, French J, Garcia R, Li Y, Casset-Semanaz F, Aydemir A, Townsend R, Mateo CV, Studham M, Guenther O, Kao A, Gastonguay M, Girard P, Benincosa L, Venkatakrishnan K. Goteti K, et al. Among authors: guenther o. CPT Pharmacometrics Syst Pharmacol. 2023 Feb;12(2):180-195. doi: 10.1002/psp4.12888. Epub 2022 Nov 29. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36350330 Free PMC article.
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.
Guehring H, Moreau F, Daelken B, Ladel C, Guenther O, Bihlet AR, Wirth W, Eckstein F, Hochberg M, Conaghan PG. Guehring H, et al. Among authors: guenther o. Semin Arthritis Rheum. 2021 Apr;51(2):450-456. doi: 10.1016/j.semarthrit.2021.03.005. Epub 2021 Mar 11. Semin Arthritis Rheum. 2021. PMID: 33752164 Free article. Clinical Trial.
Accounting serves four purposes.
GUENTHER O. GUENTHER O. Mod Hosp. 1946 May;66(5):73-5. Mod Hosp. 1946. PMID: 21066592 No abstract available.
[THE DEVELOPMENT OF IMMUNITY].
GUENTHER O. GUENTHER O. Dtsch Med Wochenschr. 1964 Dec 25;89:2449-54. doi: 10.1055/s-0028-1113302. Dtsch Med Wochenschr. 1964. PMID: 14223823 German. No abstract available.
38 results